Neonatal survival: A call for action

Jose Martines, Vinod K. Paul, Zulfiqar A. Bhutta, Marjorie Koblinsky, Agnes Soucat, Neff Walker, Rajiv Bahl, Helga Fogstad, Anthony Costello

Research output: Contribution to journalArticle

Abstract

To achieve the Millennium Development Goal for child survival (MDG-4), neonatal deaths need to be prevented. Previous papers in this series have presented the size of the problem, discussed cost-effective interventions, and outlined a systematic approach to overcoming health-system constraints to scaling up. We address issues related to improving neonatal survival. Countries should not wait to initiate action. Success is possible in low-income countries and without highly developed technology. Effective, low-cost interventions exist, but are not present in programmes. Specific efforts are needed by safe motherhood and child survival programmes. Improved availability of skilled care during childbirth and family/community-based care through postnatal home visits will benefit mothers and their newborn babies. Incorporation of management of neonatal illness into the integrated management of childhood illness initiative (IMCI) will improve child survival. Engagement of the community and promotion of demand for care are crucial. To halve neonatal mortality between 2000 and 2015 should be one of the targets of MDG-4. Development, implementation, and monitoring of national action plans for neonatal survival is a priority. We estimate the running costs of the selected packages at 90% coverage in the 75 countries with the highest mortality rates to be US$4·1 billion a year, in addition to current expenditures of $2·0 billion. About 30% of this money would be for interventions that have specific benefit for the newborn child; the remaining 70% will also benefit mothers and older children, and substantially reduce rates of stillbirths. The cost per neonatal death averted is estimated at $2100 (range $1700-3100). Maternal, neonatal, and child health receive little funding relative to the large numbers of deaths. International donors and leaders of developing countries should be held accountable for meeting their commitments and increasing resources.

Original languageEnglish (US)
Pages (from-to)1189-1197
Number of pages9
JournalThe Lancet
Volume365
Issue number9465
DOIs
StatePublished - Mar 26 2005
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Mothers
Newborn Infant
Postnatal Care
House Calls
Stillbirth
Infant Mortality
Health Expenditures
Child Development
Developing Countries
Tissue Donors
Parturition
Technology
Mortality
Health
Perinatal Death
Infant Health
Child Health
Maternal Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Martines, J., Paul, V. K., Bhutta, Z. A., Koblinsky, M., Soucat, A., Walker, N., ... Costello, A. (2005). Neonatal survival: A call for action. The Lancet, 365(9465), 1189-1197. https://doi.org/10.1016/S0140-6736(05)71882-1

Neonatal survival : A call for action. / Martines, Jose; Paul, Vinod K.; Bhutta, Zulfiqar A.; Koblinsky, Marjorie; Soucat, Agnes; Walker, Neff; Bahl, Rajiv; Fogstad, Helga; Costello, Anthony.

In: The Lancet, Vol. 365, No. 9465, 26.03.2005, p. 1189-1197.

Research output: Contribution to journalArticle

Martines, J, Paul, VK, Bhutta, ZA, Koblinsky, M, Soucat, A, Walker, N, Bahl, R, Fogstad, H & Costello, A 2005, 'Neonatal survival: A call for action', The Lancet, vol. 365, no. 9465, pp. 1189-1197. https://doi.org/10.1016/S0140-6736(05)71882-1
Martines J, Paul VK, Bhutta ZA, Koblinsky M, Soucat A, Walker N et al. Neonatal survival: A call for action. The Lancet. 2005 Mar 26;365(9465):1189-1197. https://doi.org/10.1016/S0140-6736(05)71882-1
Martines, Jose ; Paul, Vinod K. ; Bhutta, Zulfiqar A. ; Koblinsky, Marjorie ; Soucat, Agnes ; Walker, Neff ; Bahl, Rajiv ; Fogstad, Helga ; Costello, Anthony. / Neonatal survival : A call for action. In: The Lancet. 2005 ; Vol. 365, No. 9465. pp. 1189-1197.
@article{fd2ac8d2edd349428be990f0f47eb612,
title = "Neonatal survival: A call for action",
abstract = "To achieve the Millennium Development Goal for child survival (MDG-4), neonatal deaths need to be prevented. Previous papers in this series have presented the size of the problem, discussed cost-effective interventions, and outlined a systematic approach to overcoming health-system constraints to scaling up. We address issues related to improving neonatal survival. Countries should not wait to initiate action. Success is possible in low-income countries and without highly developed technology. Effective, low-cost interventions exist, but are not present in programmes. Specific efforts are needed by safe motherhood and child survival programmes. Improved availability of skilled care during childbirth and family/community-based care through postnatal home visits will benefit mothers and their newborn babies. Incorporation of management of neonatal illness into the integrated management of childhood illness initiative (IMCI) will improve child survival. Engagement of the community and promotion of demand for care are crucial. To halve neonatal mortality between 2000 and 2015 should be one of the targets of MDG-4. Development, implementation, and monitoring of national action plans for neonatal survival is a priority. We estimate the running costs of the selected packages at 90{\%} coverage in the 75 countries with the highest mortality rates to be US$4·1 billion a year, in addition to current expenditures of $2·0 billion. About 30{\%} of this money would be for interventions that have specific benefit for the newborn child; the remaining 70{\%} will also benefit mothers and older children, and substantially reduce rates of stillbirths. The cost per neonatal death averted is estimated at $2100 (range $1700-3100). Maternal, neonatal, and child health receive little funding relative to the large numbers of deaths. International donors and leaders of developing countries should be held accountable for meeting their commitments and increasing resources.",
author = "Jose Martines and Paul, {Vinod K.} and Bhutta, {Zulfiqar A.} and Marjorie Koblinsky and Agnes Soucat and Neff Walker and Rajiv Bahl and Helga Fogstad and Anthony Costello",
year = "2005",
month = "3",
day = "26",
doi = "10.1016/S0140-6736(05)71882-1",
language = "English (US)",
volume = "365",
pages = "1189--1197",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9465",

}

TY - JOUR

T1 - Neonatal survival

T2 - A call for action

AU - Martines, Jose

AU - Paul, Vinod K.

AU - Bhutta, Zulfiqar A.

AU - Koblinsky, Marjorie

AU - Soucat, Agnes

AU - Walker, Neff

AU - Bahl, Rajiv

AU - Fogstad, Helga

AU - Costello, Anthony

PY - 2005/3/26

Y1 - 2005/3/26

N2 - To achieve the Millennium Development Goal for child survival (MDG-4), neonatal deaths need to be prevented. Previous papers in this series have presented the size of the problem, discussed cost-effective interventions, and outlined a systematic approach to overcoming health-system constraints to scaling up. We address issues related to improving neonatal survival. Countries should not wait to initiate action. Success is possible in low-income countries and without highly developed technology. Effective, low-cost interventions exist, but are not present in programmes. Specific efforts are needed by safe motherhood and child survival programmes. Improved availability of skilled care during childbirth and family/community-based care through postnatal home visits will benefit mothers and their newborn babies. Incorporation of management of neonatal illness into the integrated management of childhood illness initiative (IMCI) will improve child survival. Engagement of the community and promotion of demand for care are crucial. To halve neonatal mortality between 2000 and 2015 should be one of the targets of MDG-4. Development, implementation, and monitoring of national action plans for neonatal survival is a priority. We estimate the running costs of the selected packages at 90% coverage in the 75 countries with the highest mortality rates to be US$4·1 billion a year, in addition to current expenditures of $2·0 billion. About 30% of this money would be for interventions that have specific benefit for the newborn child; the remaining 70% will also benefit mothers and older children, and substantially reduce rates of stillbirths. The cost per neonatal death averted is estimated at $2100 (range $1700-3100). Maternal, neonatal, and child health receive little funding relative to the large numbers of deaths. International donors and leaders of developing countries should be held accountable for meeting their commitments and increasing resources.

AB - To achieve the Millennium Development Goal for child survival (MDG-4), neonatal deaths need to be prevented. Previous papers in this series have presented the size of the problem, discussed cost-effective interventions, and outlined a systematic approach to overcoming health-system constraints to scaling up. We address issues related to improving neonatal survival. Countries should not wait to initiate action. Success is possible in low-income countries and without highly developed technology. Effective, low-cost interventions exist, but are not present in programmes. Specific efforts are needed by safe motherhood and child survival programmes. Improved availability of skilled care during childbirth and family/community-based care through postnatal home visits will benefit mothers and their newborn babies. Incorporation of management of neonatal illness into the integrated management of childhood illness initiative (IMCI) will improve child survival. Engagement of the community and promotion of demand for care are crucial. To halve neonatal mortality between 2000 and 2015 should be one of the targets of MDG-4. Development, implementation, and monitoring of national action plans for neonatal survival is a priority. We estimate the running costs of the selected packages at 90% coverage in the 75 countries with the highest mortality rates to be US$4·1 billion a year, in addition to current expenditures of $2·0 billion. About 30% of this money would be for interventions that have specific benefit for the newborn child; the remaining 70% will also benefit mothers and older children, and substantially reduce rates of stillbirths. The cost per neonatal death averted is estimated at $2100 (range $1700-3100). Maternal, neonatal, and child health receive little funding relative to the large numbers of deaths. International donors and leaders of developing countries should be held accountable for meeting their commitments and increasing resources.

UR - http://www.scopus.com/inward/record.url?scp=15744379507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744379507&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(05)71882-1

DO - 10.1016/S0140-6736(05)71882-1

M3 - Article

C2 - 15794974

AN - SCOPUS:15744379507

VL - 365

SP - 1189

EP - 1197

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9465

ER -